How big could the market for Renzapride be?
When I originally bought this stock (must be 6 or 7 years ago) they never had Cetilistat in their portfolio, Renzapride was their main candidate back then. I had always considered Renzapride to more likely become the block buster drug. Sold out a few years ago for a nice fat profit (pardon the pun) and bought back in last week after the institutional placing. Not much seems to have happened in my absence but then, Rome wasn't built in a day.
Renzapride seems to be ignored by most, why is that? Have the competition moved in while I was away?